Results
Marksans Pharma Q4 Net Profit Jumps 64.3% YoY
Marksans Pharma reported Q4 FY26 revenue of ₹856 crore, up 20.8% YoY, with net profit surging 64.3% to ₹149 crore.
The company achieved its highest-ever annual revenue of ₹2,951 crore and maintained a
